Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 34561-34570 Newer>

The Motley Fool February 9, 2009 Rick Aristotle Munarriz	25 Random Things About Mr. Market Everyone seems to have an opinion -- good, bad, or ugly -- on the "25 Random Things About Me" viral phenomena that is sweeping through Facebook. Millions have apparently poured out their hearts in the meme's exercise. Now it's Wall Street's turn.
The Motley Fool February 9, 2009 Brian Orelli	ViroPharma Cut in Half ViroPharma's phase 3 drug, maribavir, failed to show an effect in reducing cytomegalovirus (CMV) disease in stem cell transplant patients, and the stock gets axed in half.
The Motley Fool February 9, 2009 Anders Bylund	JDSU Measures Twice, Cuts Once Communications test and measurement specialist JDS Uniphase is doing OK in the downturn.
The Motley Fool February 9, 2009 Robert Steyer	Just Say No to Drug Company Mergers There are some reasons to make a big-pharma deal. But there are as many, if not more, reasons to let these companies pursue smaller deals and collaborations rather than become just another part of a hyphenated corporate name.
The Motley Fool February 9, 2009 Rick Aristotle Munarriz	Hasbro Lands on the Island of Misfit Toys Hasbro's six-quarter-streak of beating expectations comes to an end.
The Motley Fool February 9, 2009	2 Stocks Hitting High Notes These stocks are bucking the trend and hitting new highs. Take a look at: Myriad Genetics... Hot Topic...
The Motley Fool February 9, 2009 Alyce Lomax	Weighing Starbucks' Values Starbucks is following in the footsteps of the likes of McDonald's into "value meal" territory during the breakfast hours. Are value meals at Starbucks brilliant, or will they kill the brand?
The Motley Fool February 9, 2009 Anders Bylund	Gaming Is a Safe Bet Thanks to the seemingly insatiable Chinese appetite for games, Sohu.com, the online gaming giant, reported 86% higher earnings year over year.
The Motley Fool February 9, 2009 Matt Koppenheffer	Are Stadium Naming Rights a Stock Hex? Here's a theory -- when any one industry starts to snatch up all the naming rights for sports stadiums, like banks now, it's time to start selling stocks in that industry.
The Motley Fool February 9, 2009 Toby Shute	Evergreen Solar Too Slow to Shine Evergreen needs to hit an adequate scale in order to beef up margins and really compete with fast-growing firms like SunPower and First Solar.
<Older 34561-34570 Newer> Return to current articles.